Takeda Partner Sucampo Scraps Amitiza NDA In Europe
This article was originally published in PharmAsia News
Executive Summary
Takeda U.S. partner Sucampo announced a cancellation of the NDA in Europe for chronic idiopathic constipation drug Amitiza (lubiprostone)